Eterna Therapeutics Inc (ERNA) stock news · rev $582.0K
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
This ERNA news page leads with what Eterna Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for ERNA yet. We will not pad this page with generic market recap.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ERNA stock page; for the tape open the quote page.
ERNA stock news FAQ
What are ERNA's latest revenue and net income?
Latest cached Eterna Therapeutics Inc (ERNA) revenue for Dec 31, 2024 was $582.0K. Net income was -$44.5M. Statements: https://lician.com/financials/erna
How did ERNA revenue change from the prior cached period?
Cached Eterna Therapeutics Inc (ERNA) revenue was up 755.9% from $68.0K (Dec 31, 2023) to $582.0K (Dec 31, 2024). Statements: https://lician.com/financials/erna
What is ERNA's market cap?
Eterna Therapeutics Inc (ERNA) market cap is $6.9M on the latest cached fundamentals snapshot.
What kind of company is ERNA?
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Where is ERNA stock news listed?
Cached stock news for Eterna Therapeutics Inc (ERNA) is listed at https://lician.com/news/erna. Filings: https://lician.com/sec/erna
Not investment advice.